Asset Dedication, LLC Dexcom Inc Transaction History

Asset Dedication, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 19, 2023	BUY	$84.98 - $122.67 $169 - $245	2 New	2 $0
Q2 2022 Jul 19, 2022	SELL	$67.99 - $132.89 $2,787 - $5,448	-41 Closed	0 $0
Q3 2021 Oct 18, 2021	BUY	$106.71 - $143.18 $4,375 - $5,870	41 New	41 $22,000
Q1 2021 May 03, 2021	SELL	$84.79 - $104.74 $339 - $418	-4 Closed	0 $0
Q3 2020 Oct 20, 2020	BUY	$95.51 - $112.95 $382 - $451	4 New	4 $2,000
Q1 2020 May 05, 2020	SELL	$47.79 - $75.63 $191 - $302	-4 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$36.62 - $57.29 $146 - $229	4 New	4 $1,000
Q4 2018 Feb 12, 2019	SELL	$26.99 - $37.37 $809 - $1,121	-30 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$23.35 - $36.72 $1,681 - $2,643	-72 Reduced 70.59%	30 $4,000
Q2 2018 Aug 13, 2018	BUY	$17.54 - $25.22 $1,789 - $2,572	102 New	102 $10,000
Q1 2018 Apr 19, 2018	SELL	$13.06 - $18.54 $1,854 - $2,632	-142 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$11.36 - $18.98 $1,613 - $2,695	142	142 $7,000

1,016

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Asset Dedication, LLC, based on Form 13F filings with the SEC.

Stay updated on Asset Dedication, LLC with notifications on news.